Pfizer News
- All
- News
- Videos
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
- Thursday January 25, 2024
- World News | Asian News International
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
- www.ndtv.com
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
- Wednesday February 8, 2023
- India News | Asian News International
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
- www.ndtv.com
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
- Friday January 20, 2023
- World News | Asian News International
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
- www.ndtv.com
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
- Tuesday December 27, 2022
- World News | Asian News International
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
- www.ndtv.com
-
Drug Firm Pfizer's Managing Director S Sridhar Resigns To Take Early Retirement
- Wednesday August 10, 2022
- Business | Press Trust of India
Drug firm Pfizer on Wednesday said its Managing Director S Sridhar has resigned from the company.
- www.ndtv.com/business
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
- Wednesday June 15, 2022
- World News | Agence France-Presse
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
- www.ndtv.com
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
- Monday May 23, 2022
- World News | Agence France-Presse
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
- www.ndtv.com
-
Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai
- Wednesday May 4, 2022
- Chennai News | Asian News International
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
- www.ndtv.com
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
- Wednesday April 13, 2022
- India News | Asian News International
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
- www.ndtv.com
-
2 Babies In Hospital After Pfizer Shot Given By Mistake In Brazil: Report
- Monday December 6, 2021
- World News | Asian News International
Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalised, Brazilian media report.
- www.ndtv.com
-
Covid Vaccine Booster Shots Roll Out For Australians As Curbs Ease
- Monday November 8, 2021
- World News | Reuters
Australia began administering booster shots of Pfizer's COVID-19 vaccine on Monday as millions of people in its largest city, Sydney, woke up to more freedom amid an accelerating immunisation drive.
- www.ndtv.com
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
- Friday August 27, 2021
- World News | Asian News International
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
- www.ndtv.com
-
Expert Group In Talks With Pfizer For Vaccine Supply: Health Minister
- Friday July 23, 2021
- India News | Asian News International
An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
- www.ndtv.com
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
- Wednesday July 21, 2021
- World News | Reuters
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
- www.ndtv.com
-
India Has Been Offered 7.5 Million Doses Of Moderna COVID-19 Vaccine Through COVAX: WHO
- Tuesday July 20, 2021
- India News | Asian News International
The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
- www.ndtv.com
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
- Thursday January 25, 2024
- World News | Asian News International
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
- www.ndtv.com
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
- Wednesday February 8, 2023
- India News | Asian News International
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
- www.ndtv.com
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
- Friday January 20, 2023
- World News | Asian News International
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
- www.ndtv.com
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
- Tuesday December 27, 2022
- World News | Asian News International
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
- www.ndtv.com
-
Drug Firm Pfizer's Managing Director S Sridhar Resigns To Take Early Retirement
- Wednesday August 10, 2022
- Business | Press Trust of India
Drug firm Pfizer on Wednesday said its Managing Director S Sridhar has resigned from the company.
- www.ndtv.com/business
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
- Wednesday June 15, 2022
- World News | Agence France-Presse
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
- www.ndtv.com
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
- Monday May 23, 2022
- World News | Agence France-Presse
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
- www.ndtv.com
-
Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai
- Wednesday May 4, 2022
- Chennai News | Asian News International
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
- www.ndtv.com
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
- Wednesday April 13, 2022
- India News | Asian News International
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
- www.ndtv.com
-
2 Babies In Hospital After Pfizer Shot Given By Mistake In Brazil: Report
- Monday December 6, 2021
- World News | Asian News International
Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalised, Brazilian media report.
- www.ndtv.com
-
Covid Vaccine Booster Shots Roll Out For Australians As Curbs Ease
- Monday November 8, 2021
- World News | Reuters
Australia began administering booster shots of Pfizer's COVID-19 vaccine on Monday as millions of people in its largest city, Sydney, woke up to more freedom amid an accelerating immunisation drive.
- www.ndtv.com
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
- Friday August 27, 2021
- World News | Asian News International
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
- www.ndtv.com
-
Expert Group In Talks With Pfizer For Vaccine Supply: Health Minister
- Friday July 23, 2021
- India News | Asian News International
An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
- www.ndtv.com
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
- Wednesday July 21, 2021
- World News | Reuters
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
- www.ndtv.com
-
India Has Been Offered 7.5 Million Doses Of Moderna COVID-19 Vaccine Through COVAX: WHO
- Tuesday July 20, 2021
- India News | Asian News International
The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
- www.ndtv.com